ABBVIE Chart calendar AbbVie
5b564abba29209e0.T5MHeT3T3ebcYuCi7Bp_TfQUJn7UHIajSCJYjUnLj80.I9szAG6-m6mpWtTRpWMMeJBkTg6_X8_2eX006RiS5fQ4xnZOSb2btulU0A~93acef3b3a5e2083b8e4cdd8a843ee8c
Upcoming events on AbbVie
Past events on AbbVie
| 2024-06-03 03:15 pm | American Society of Clinical Oncology Meeting - Abstract No: 3515 |
| 2024-06-02 11:01 am | American Society of Clinical Oncology Meeting - Abstract No: 103 |
| 2024-06-01 04:12 pm | American Society of Clinical Oncology Meeting - Abstract No: 3001 |
| 2024-05-15 01:40 pm | BofA Securities Health Care Conference |
| 2024-05-03 10:00 am | Annual General Meeting |
| 2024-04-26 09:00 am | Q1 2024 Earnings Call |
| 2024-04-26 07:35 am | Q1 2024 Earnings Release |
| 2024-04-11 | Détachement de |
| 2024-03-27 11:30 am | Anti-Aging and Aesthetics Medicine World Congress |
| 2024-03-27 09:00 am | Anti-Aging and Aesthetics Medicine World Congress |
| 2024-03-27 06:15 am | Anti-Aging and Aesthetics Medicine World Congress |
| 2024-03-27 04:45 am | Anti-Aging and Aesthetics Medicine World Congress |
| 2024-03-14 09:00 am | Barclays Global Healthcare Conference |
| 2024-03-10 05:45 pm | American Academy of Dermatology Meeting |
| 2024-03-10 05:40 pm | American Academy of Dermatology Meeting |
| 2024-03-10 05:30 pm | American Academy of Dermatology Meeting |
| 2024-03-09 06:30 pm | American Academy of Dermatology Meeting |
| 2024-03-09 06:10 pm | American Academy of Dermatology Meeting |
| 2024-03-09 06:00 pm | American Academy of Dermatology Meeting |
| 2024-03-09 05:25 pm | American Academy of Dermatology Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 33 266 33 255 0.03% | 45 784 45 637 0.32% | 56 122 56 238 -0.21% | 58 054 58 284 -0.4% | 54 318 54 047 0.5% | 55 175 |
|
EBITDA Million USD | Released Forecast Spread | 17 747 16 811 5.57% | 22 642 22 766 -0.54% | 29 018 29 168 -0.51% | 30 961 31 181 -0.7% | 25 545 25 858 -1.21% | 26 357 |
|
EBIT Million USD | Released Forecast Spread | 15 730 15 736 -0.04% | 21 976 21 832 0.66% | 28 215 28 167 0.17% | 30 183 30 154 0.1% | 24 793 24 926 -0.53% | 25 528 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8 426 12 085 -30.28% | 3 398 14 347 -76.32% | 12 989 12 579 3.26% | 13 477 16 796 -19.76% | 6 250 8 933 -30.04% | 12 004 |
|
Net income Million USD | Released Forecast Spread | 7 882 7 753 1.66% | 4 616 7 357 -37.26% | 11 542 11 140 3.61% | 11 836 14 494 -18.34% | 4 863 8 288 -41.32% | 7 739 |
|
EPS USD | Released Forecast Spread | 5,28 5,23 0.97% | 2,72 4,27 -36.28% | 6,45 6,25 3.27% | 6,63 8,28 -19.89% | 2,72 5,30 -48.69% | 5,33 |
| Announcement Date | 07/02/20 | 03/02/21 | 02/02/22 | 09/02/23 | 02/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13 538 13 613 -0.55% | 14 583 14 640 -0.39% | 14 812 14 944 -0.89% | 15 121 15 337 -1.41% | 12 225 12 230 -0.04% | 13 865 13 520 2.55% | 13 927 13 707 1.6% | 14 301 14 027 1.96% | 12 310 11 936 3.14% | 14 008 | 14 179 | 14 716 | 13 237 | 14 315 |
|
EBITDA Million USD | Released Forecast Spread | 7 156 7 115 0.58% | 7 643 8 083 -5.45% | 8 090 8 645 -6.42% | 8 072 8 405 -3.96% | 5 682 5 686 -0.06% | 6 710 6 633 1.16% | 6 706 6 681 0.37% | 6 447 6 600 -2.32% | 5 444 | 7 100 | 6 877 | 7 049 | ||
|
EBIT Million USD | Released Forecast Spread | 6 958 6 972 -0.21% | 7 440 7 382 0.78% | 7 909 7 843 0.85% | 7 876 7 778 1.26% | 5 503 5 553 -0.9% | 6 520 6 398 1.9% | 6 510 6 498 0.19% | 6 260 6 391 -2.05% | 5 195 5 158 0.71% | 6 888 | 6 702 | 6 793 | 6 659 | 6 996 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 475 5 059 -90.61% | 2 610 3 685 -29.17% | 1 953 3 960 -50.68% | 1 212 3 839 -68.43% | 1 755 2 367 -25.86% | 3 504 | 3 346 | 3 397 | ||||||
|
Net income Million USD | Released Forecast Spread | 4 490 3 473 29.3% | 924 4 067 -77.28% | 3 949 5 207 -24.16% | 2 473 3 781 -34.59% | 239 2 405 -90.06% | 2 024 2 570 -21.25% | 1 778 2 937 -39.46% | 822 1 580 -47.98% | 1 369 1 220 12.17% | 2 264 | 2 053 | 2 002 | 1 115 | 1 400 |
|
EPS USD | Released Forecast Spread | 2,51 2,03 23.44% | 0,51 2,13 -76.06% | 2,21 2,87 -22.91% | 1,38 2,71 -49.14% | 0,13 1,42 -90.82% | 1,14 1,43 -20.46% | 1,00 1,72 -41.86% | 0,46 2,00 -76.95% | 0,77 0,66 16.08% | 1,57 | 1,36 | 1,38 | 0,62 | 0,78 |
| Announcement Date | 29/04/22 | 29/07/22 | 28/10/22 | 09/02/23 | 27/04/23 | 27/07/23 | 27/10/23 | 02/02/24 | 26/04/24 | - | - | - | - | - |
More events
Past sector events for AbbVie
| 2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
